EXICURE, INC. Increase (Decrease) in Other Operating Liabilities
EXICURE, INC. (XCUR) reported Increase (Decrease) in Other Operating Liabilities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-03-25
- EXICURE, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $0.00.
- EXICURE, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was $0.00.
- EXICURE, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-06-30 was $0.00.
- EXICURE, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-03-31 was $0.00.
- EXICURE, INC. increase (decrease) in other operating liabilities for fiscal 2025 was $0.00.
- EXICURE, INC. increase (decrease) in other operating liabilities for fiscal 2024 was -$827.00K.
- EXICURE, INC. increase (decrease) in other operating liabilities for fiscal 2023 was -$728.00K.
- EXICURE, INC. increase (decrease) in other operating liabilities for fiscal 2022 was -$637.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | -$218.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | -$218.00K derived: sum of 3 quarters · filed 2026-03-25 | -$432.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-03-31 | $0.00 10-Q · filed 2025-06-27 | -$218.00K derived: sum of 2 quarters · filed 2026-03-25 | -$432.00K derived: sum of 3 quarters · filed 2026-03-25 | -$631.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | -$218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$432.00K derived: sum of 2 quarters · filed 2026-03-25 | -$631.00K derived: sum of 3 quarters · filed 2026-03-25 | -$827.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | -$214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$413.00K derived: sum of 2 quarters · filed 2025-11-07 | -$609.00K 10-Q · filed 2025-11-07 | -$801.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$395.00K 10-Q · filed 2025-08-08 | -$587.00K derived: sum of 3 quarters · filed 2025-08-08 | -$776.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$196.00K 10-Q · filed 2025-06-27 | -$388.00K derived: sum of 2 quarters · filed 2025-06-27 | -$577.00K derived: sum of 3 quarters · filed 2025-06-27 | -$752.00K derived: sum of 4 quarters · filed 2025-06-27 |
| 2023-12-31 | -$192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$381.00K derived: sum of 2 quarters · filed 2025-03-18 | -$556.00K derived: sum of 3 quarters · filed 2025-03-18 | -$728.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | -$189.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$364.00K derived: sum of 2 quarters · filed 2024-11-14 | -$536.00K 10-Q · filed 2024-11-14 | -$704.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$347.00K 10-Q · filed 2024-08-13 | -$515.00K derived: sum of 3 quarters · filed 2024-08-13 | -$681.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$172.00K 10-Q · filed 2024-06-17 | -$340.00K derived: sum of 2 quarters · filed 2024-06-17 | -$506.00K derived: sum of 3 quarters · filed 2024-06-17 | -$659.00K derived: sum of 4 quarters · filed 2024-06-17 |
| 2022-12-31 | -$168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | -$334.00K derived: sum of 2 quarters · filed 2024-06-06 | -$487.00K derived: sum of 3 quarters · filed 2024-06-06 | -$637.00K 10-K · filed 2024-06-06 |
| 2022-09-30 | -$166.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | -$319.00K derived: sum of 2 quarters · filed 2024-06-06 | -$469.00K 10-Q · filed 2024-05-16 | -$616.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-06-30 | -$153.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | -$303.00K 10-Q/A · filed 2024-06-06 | -$450.00K derived: sum of 3 quarters · filed 2024-06-06 | -$595.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-03-31 | -$150.00K 10-Q/A · filed 2024-06-06 | -$297.00K derived: sum of 2 quarters · filed 2024-06-06 | -$442.00K derived: sum of 3 quarters · filed 2024-06-06 | -$575.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2021-12-31 | -$147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$292.00K derived: sum of 2 quarters · filed 2023-03-27 | -$425.00K derived: sum of 3 quarters · filed 2023-03-27 | -$555.00K 10-K · filed 2023-03-27 |
| 2021-09-30 | -$145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$278.00K derived: sum of 2 quarters · filed 2022-11-14 | -$408.00K 10-Q · filed 2022-11-14 | -$536.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$263.00K 10-Q · filed 2022-08-15 | -$391.00K derived: sum of 3 quarters · filed 2022-08-15 | -$451.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$130.00K 10-Q · filed 2022-05-16 | -$258.00K derived: sum of 2 quarters · filed 2022-05-16 | -$318.00K derived: sum of 3 quarters · filed 2022-05-16 | -$318.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$188.00K derived: sum of 2 quarters · filed 2022-03-25 | -$188.00K derived: sum of 3 quarters · filed 2022-03-25 | -$247.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | -$60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | -$60.00K derived: sum of 2 quarters · filed 2021-11-19 | -$119.00K 10-Q · filed 2021-11-19 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$59.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$59.00K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | -$322.00K 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |